CIK 0001829802 · <br>Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 2,843 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 5,891 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,627 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 500 shares at $0.85 ($425)
- 4 Shares withheld for taxes Chief Business Officer gave up 9,383 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 9,525 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 20,492 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 10,943 shares (to pay taxes)
- 4 Returned to the company 10% owner returned 1,587,302 shares (to the company)
- 4 Returned to the company Director returned 1,587,302 shares (to the company)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
- 4 Grant or award Director acquired 4,466 shares (grant or award)
Page 4 of 13 · 245 filings